CLAZF OTC
Claritas Pharmaceuticals, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: -99.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$309K
+95.2% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$309K
+95.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$44K
+77.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$12M | -$32M | $7M | -$21M | $4M |
| Depreciation & Amort. | $19K | $0 | $0 | $33M | $18M |
| Stock-Based Comp. | $448K | $346K | $875K | $3K | $344 |
| Change in Working Capital | $2M | -$690K | $1M | -$4M | -$6M |
| Other Non-Cash Items | $8M | $27M | -$14M | -$15M | -$12M |
| Operating Cash Flow | -$2M | -$6M | -$5M | -$6M | -$309K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | -$10M | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$8K | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $2K |
| Other Investing | $0 | $0 | $0 | -$180K | $2 |
| Investing Cash Flow | $0 | -$10M | $0 | -$188K | $2K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $4M | $0 | $292K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $16K | -$2M | $0 | $295K |
| Financing Cash Flow | $2M | $19M | $1M | $6M | $295K |
| Net Change in Cash | $51K | $3M | -$3M | -$195K | -$44K |
| Cash End of Period | $673K | $4M | $227K | $32K | -$12K |
| Free Cash Flow | -$2M | -$6M | -$5M | -$6M | -$309K |